[1] Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001; 60: 1443-1451.http://www.ncbi.nlm.nih.gov/pubmed/11576358
[2] Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002; 62(2): 620-626.
[3] Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int. 2005; 68: 311-318.http://www.ncbi.nlm.nih.gov/pubmed/15954922
[4] Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin. J Am Soc Nephrol. 2007; 2: 89-99.http://www.ncbi.nlm.nih.gov/pubmed/17699392
[5] KDOQI Clinical practice guidelines and clinical practice recommendations for vascular access. Am. J Kidney Dis. 2006; 48 Suppl 1: S176-S247.http://www.ncbi.nlm.nih.gov/pubmed/16813989
[6] Lok CE. Fistula first initiative: advantages and pitfalls. Clin. J Am. Soc. Nephrol. 2007; 2: 1043-1053.http://www.ncbi.nlm.nih.gov/pubmed/17702726
[7] Lee T. Fistula First Initiative: Historical Impact on Vascular Access Practice Patterns and Influence on Future Vascular Access Care. Cardiovascular engineering and technology. 2017; 8: 244-254.
[8] U.S.Renal Data System USRDS 2019 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases . Bethesda MD.
[9] Berger JR, Hedayati SS. Renal replacement therapy in the elderly population. Clin. J Am. Soc. Nephrol. 2012; 7: 1039-1046.http://www.ncbi.nlm.nih.gov/pubmed/22516288
[10] Winchester JF. Special clinical problems in geriatric patients. Semin. Dial. 2002; 15: 116-120.http://www.ncbi.nlm.nih.gov/pubmed/11952939
[11] Singh P, Germain MJ, Cohen L, Unruh M. The elderly patient on dialysis: geriatric considerations. Nephrol. Dial. Transplant. 2014; 29: 990-996.http://www.ncbi.nlm.nih.gov/pubmed/23787545
[12] Canaud B, Tong L, Tentori F, Akiba T, Karaboyas A, Gillespie B, Akizawa T, Pisoni RL, Bommer J, Port FK. Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin. J Am. Soc. Nephrol. 2011; 6: 1651-1662.http://www.ncbi.nlm.nih.gov/pubmed/21734085
[13] Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Ann. Intern. Med. 2007; 146: 177-183.http://www.ncbi.nlm.nih.gov/pubmed/17283348
[14] Robinson BM, Zhang J, Morgenstern H, Bradbury BD, Ng LJ, McCullough KP, Gillespie BW, Hakim R, Rayner H, Fort J, Akizawa T, Tentori F, Pisoni RL. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int. 2014; 85: 158-165.http://www.ncbi.nlm.nih.gov/pubmed/23802192
[15] Hall RK, Myers ER, Rosas SE, O'Hare AM, Colon-Emeric CS. Choice of Hemodialysis Access in Older Adults: A Cost-Effectiveness Analysis. Clin J Am Soc Nephrol. 2017; 12: 947-954.http://www.ncbi.nlm.nih.gov/pubmed/28522655
[16] Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ. An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int. 2010; 77: 141-151.http://www.ncbi.nlm.nih.gov/pubmed/19907414
[17] Kan WC, Wang JJ, Wang SY, Sun YM, Hung CY, Chu CC, Lu CL, Weng SF, Chio CC, Chien CC. The new comorbidity index for predicting survival in elderly dialysis patients: a long-term population-based study. PLoS. One. 2013; 8: e68748.http://www.ncbi.nlm.nih.gov/pubmed/23936310
[18] Brown RS, Patibandla BK, Goldfarb-Rumyantzev AS. The Survival Benefit of "Fistula First, Catheter Last" in Hemodialysis Is Primarily Due to Patient Factors. J Am Soc Nephrol. 2017; 28: 645-652.http://www.ncbi.nlm.nih.gov/pubmed/27605542
[19] Lok CE, Sontrop JM, Tomlinson G, Rajan D, Cattral M, Oreopoulos G, Harris J, Moist L. Cumulative patency of contemporary fistulas versus grafts (2000-2010). Clin. J Am Soc Nephrol. 2013; 8: 810-818.http://www.ncbi.nlm.nih.gov/pubmed/23371955
[20] Lok C. .(Lok CE. Updated KDOQI Guidelines on Vascular Access: What to Expect. . Endovascular Today. 2017: 36-37.
[21] Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol. 2006; 17: 3204-3212.http://www.ncbi.nlm.nih.gov/pubmed/16988062
[22] Richardson AI, Leake A, Schmieder GC, Biuckians A, Stokes GK, Panneton JM, Glickman MH. Should fistulas really be first in the elderly patient? J Vasc. Access. 2009; 10: 199-202.http://www.ncbi.nlm.nih.gov/pubmed/19670174
[23] Lazarides MK, Georgiadis GS, Antoniou GA, Staramos DN. A meta-analysis of dialysis access outcome in elderly patients. J Vasc. Surg. 2007; 45: 420-426.http://www.ncbi.nlm.nih.gov/pubmed/17264030
[24] Cui J, Steele D, Wenger J, Kawai T, Liu F, Elias N, Watkins MT, Irani Z. Hemodialysis arteriovenous fistula as first option not necessary in elderly patients. J Vasc Surg. 2016; 63: 1326-1332.
[25] Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, Thabane M, Giangregorio L, Goldsmith CH. A tutorial on pilot studies: the what, why and how. BMC medical research methodology. 2010; 10: 1.
[26] Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC medical research methodology. 2010; 10: 67.
[27] Murea M GR, et al. A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease. Clinical rationale and study design Contemp Clin Trials Commun. 2019; 14: 1-8.
[28] Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol. A Biol. Sci Med Sci. 2014; 69: 547-558.http://www.ncbi.nlm.nih.gov/pubmed/24737557
[29] Katz S, FORD AB, MOSKOWITZ RW, JACKSON BA, JAFFE MW. STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. JAMA. 1963; 185: 914-919.http://www.ncbi.nlm.nih.gov/pubmed/14044222
[30] Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9: 179-186.http://www.ncbi.nlm.nih.gov/pubmed/5349366
[31] Hays R, JD a, DL M, SJ C, WB C, oons SJ, arter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994; Version 1.2: 329-338.
[32] Herr KA, Garand L. Assessment and measurement of pain in older adults. Clin Geriatr. Med. 2001; 17: 457-478, vi.http://www.ncbi.nlm.nih.gov/pubmed/11459715
[33] Kosa SD, Bhola C, Lok CE. Measuring patient satisfaction with vascular access: vascular access questionnaire development and reliability testing. J Vasc. Access. 2015; 16: 200-205.http://www.ncbi.nlm.nih.gov/pubmed/25634153
[34] Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010; 7: e1000251.
[35] Shanyinde M, Pickering RM, Weatherall M. Questions asked and answered in pilot and feasibility randomized controlled trials. BMC medical research methodology. 2011; 11: 117.
[36] Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Bmj. 2011; 343: d5928.
[37] Misskey J, Faulds J, Sidhu R, Baxter K, Gagnon J, Hsiang Y. An age-based comparison of fistula location, patency, and maturation for elderly renal failure patients. J Vasc Surg. 2018; 67: 1491-1500.
[38] Lee T, Qian J, Thamer M, Allon M. Gender Disparities in Vascular Access Surgical Outcomes in Elderly Hemodialysis Patients. Am J Nephrol. 2019; 49: 11-19.